Skip to main content
Application Note

Imaging Hepatocellular Liver Injury using NIR-labeled Annexin V

imaging-hepatocellular

Drug induced liver injury (DILI) is a major reason for late stage termination of drug discovery research projects, highlighting the importance of early integration of liver safety assessment in the drug development process. A technical approach for in vivo toxicology determination using IVISense® Annexin-V fluorescent probe and IVIS® SpectrumCT imaging system was developed to evaluate Acetaminophen (APAP), a commonly used over-the-counter analgesic and antipyretic drug, to induce acute hepatocellular liver injury.

For research use only. Not for use in diagnostic procedures. 

To view the full content please answer a few questions

By submitting my personal data, I acknowledge that Revvity Inc. and its affiliates (“Company”) will process my personal data provided above consistent with the Company’s Privacy Policy available here.

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Download Resource

Imaging Hepatocellular Liver Injury using NIR-labeled Annexin V

Download Application Note